Ankle Joint Replacement Outcomes Study

Sponsor
Smith & Nephew, Inc. (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT00503438
Collaborator
(none)
76
2
1
216
38
0.2

Study Details

Study Description

Brief Summary

This post market outcome study will look at the therapeutic results of the Salto Talaris Anatomic ankle prosthesis. The study population will consist of patients who will undergo an ankle arthroplasty procedure with a Salto Talaris ankle implant. An analysis will be conducted of the results, complications and revisions of this prosthesis based on the etiology for which the ankle arthroplasty was performed.

Condition or Disease Intervention/Treatment Phase
  • Device: Salto Talaris Ankle
N/A

Detailed Description

This is a prospective, multi-center study that will capture the therapeutic results of the Salto Talaris Anatomic ankle prosthesis in the treatment of various ankle afflictions.

Study Design

Study Type:
Interventional
Actual Enrollment :
76 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Actual Study Start Date :
Oct 31, 2007
Anticipated Primary Completion Date :
Oct 29, 2025
Anticipated Study Completion Date :
Oct 29, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: Salto Talaris Ankle

This is an Implant Registry of the approved Salto Talaris Ankle replacement device

Device: Salto Talaris Ankle
Salto Talaris Anatomic Ankle total joint prosthesis
Other Names:
  • Salto Talaris
  • Outcome Measures

    Primary Outcome Measures

    1. Survivorship of Salto Talaris Ankle Implant [10 years]

      Count of participants without a failed ankle arthroplasty. Ankle arthroplasty will be considered as failed if the implant is revised or removed and the ankle fused.

    Secondary Outcome Measures

    1. The American Orthopaedic Foot and Ankle Society (AOFAS) Score [Postoperatively at 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years, 8 years, and 10 years]

      AOFAS ankle evaluation form is a commonly used standardized assessment of foot and ankle function divided into three anatomic regions. The scale used for this study will be the Ankle-Hindfoot Scale that ranges from 0 to 100. A score of 100 points is the maximum for a patient presenting in excellent condition. The score decreases as pain, limited range of motion, daily activities, joint instability, and alignment are assessed.

    Other Outcome Measures

    1. The Foot Function Index (FFI) [Postoperatively at 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years, 8 years, and 10 years]

      FFI is a specialized questionnaire answered by the patient. The questionnaire consists of three parts used to report clinical scores for the domains of activity limitation, function, and disability in patients with foot and ankle conditions. Each item rated on a 0 - 10 Likert scale. 0 represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item. Higher scores indicate decreased function.

    2. The Foot and Ankle Ability Measure (FAAM) [Postoperatively at 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years, 8 years, and 10 years]

      FAAM is a region-specific subject questionnaire to evaluate activities of daily living and sports. Answers for both scales are based on a Likert scale (4-0) of: 4 - no difficulty 3 - slight difficulty 2 - moderate difficulty 1 - extreme difficulty 0 - unable to do Patients are asked to answer each question with a single response that most clearly describes their condition. Patients are asked to mark not applicable (N/A) if the activity in question is limited by something other than their foot or ankle. A higher score indicates a higher level of physical function.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subjects that need an ankle joint replacement due to arthritis or failed prior fusion.

    • Subjects who have failed standard conservative management of their ankle condition

    Exclusion Criteria:
    • Class IV or higher anesthetic risk

    • Subjects who are not able to comply with the study procedures

    • Known contraindications to joint replacement such as active infection, complete talar necrosis, insufficient quality of bone stock, ligament laxity, severe osteopenia, Charcot's arthropathy

    • Unwilling to be followed for 5 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Foot and Ankle Center of South Texas San Antonio Texas United States 78205
    2 Medical College of Wisconsin Milwaukee Wisconsin United States 53226

    Sponsors and Collaborators

    • Smith & Nephew, Inc.

    Investigators

    • Principal Investigator: Richard Marks, Medical College of Wisconsin

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Smith & Nephew, Inc.
    ClinicalTrials.gov Identifier:
    NCT00503438
    Other Study ID Numbers:
    • T-STAS-001
    First Posted:
    Jul 18, 2007
    Last Update Posted:
    Jun 6, 2022
    Last Verified:
    Jun 1, 2022
    Keywords provided by Smith & Nephew, Inc.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 6, 2022